BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11774742)

  • 1. Suppression of urokinase expression and tumor metastasis by bikunin overexpression [mini-review].
    Kobayashi H
    Hum Cell; 2001 Sep; 14(3):233-6. PubMed ID: 11774742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin.
    Suzuki M; Kobayashi H; Tanaka Y; Hirashima Y; Kanayama N; Takei Y; Saga Y; Suzuki M; Itoh H; Terao T
    Int J Cancer; 2003 Apr; 104(3):289-302. PubMed ID: 12569552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways.
    Kobayashi H; Suzuki M; Tanaka Y; Hirashima Y; Terao T
    J Biol Chem; 2001 Jan; 276(3):2015-22. PubMed ID: 11050091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
    Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
    J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic down-regulation of phosphoinositide 3-kinase by bikunin correlates with suppression of invasion and metastasis in human ovarian cancer HRA cells.
    Kobayashi H; Suzuki M; Kanayama N; Terao T
    J Biol Chem; 2004 Feb; 279(8):6371-9. PubMed ID: 14597629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Eur J Biochem; 2002 Aug; 269(16):3945-57. PubMed ID: 12180971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis.
    Tanaka Y; Kobayashi H; Suzuki M; Hirashima Y; Kanayama N; Terao T
    Int J Cancer; 2004 Apr; 109(3):336-47. PubMed ID: 14961570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation.
    Kobayashi H; Suzuki M; Kanayama N; Terao T
    Clin Exp Metastasis; 2004; 21(2):159-66. PubMed ID: 15168733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of a hybrid gene consisting of the amino-terminal fragment of urokinase and carboxyl-terminal domain of bikunin suppresses invasion and migration of human ovarian cancer cells in vitro.
    Takei Y; Mizukami H; Saga Y; Kobayashi H; Suzuki M; Matsushita T; Ozawa K; Suzuki M
    Int J Cancer; 2005 Jan; 113(1):54-8. PubMed ID: 15386422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade.
    Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
    J Biol Chem; 2003 Mar; 278(10):7790-9. PubMed ID: 12496270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-beta and subsequently suppresses TGF-beta signalings.
    Yagyu T; Kobayashi H; Wakahara K; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    FEBS Lett; 2004 Oct; 576(3):408-16. PubMed ID: 15498571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells.
    Suzuki M; Kobayashi H; Fujie M; Nishida T; Takigawa M; Kanayama N; Terao T
    J Biol Chem; 2002 Mar; 277(10):8022-32. PubMed ID: 11777908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis.
    Kobayashi H; Sugino D; She MY; Ohi H; Hirashima Y; Shinohara H; Fujie M; Shibata K; Terao T
    Eur J Biochem; 1998 May; 253(3):817-26. PubMed ID: 9654084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of urokinase expression and invasion by a soybean Kunitz trypsin inhibitor are mediated through inhibition of Src-dependent signaling pathways.
    Inagaki K; Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Kondo T; Kurita N; Kitanaka T; Yamada Y; Sakamoto Y; Suzuki M; Kanayama N; Terao T
    J Biol Chem; 2005 Sep; 280(36):31428-37. PubMed ID: 16002410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced spontaneous metastasis in bikunin-deficient mice.
    Yagyu T; Kobayashi H; Matsuzaki H; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K
    Int J Cancer; 2006 May; 118(9):2322-8. PubMed ID: 16331631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor.
    Kobayashi H; Suzuki M; Sun GW; Hirashima Y; Terao T
    Biochim Biophys Acta; 2000 Sep; 1481(2):310-6. PubMed ID: 11018722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model.
    Kobayashi H; Fukuda Y; Yoshida R; Kanada Y; Nishiyama S; Suzuki M; Kanayama N; Terao T
    Int J Cancer; 2004 Nov; 112(3):519-24. PubMed ID: 15382080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
    Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
    Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
    Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.